Eupraxia Pharmaceuticals is trading at $6.20 (-5.34%) following a significant 9.72% gain on July 30, with no new company-specific news, filings, or analyst actions identified to explain the move.
- The decline appears to be a pullback after the prior session’s rebound.
- The stock's movement is consistent with a weaker tone in the healthcare sector, which is down 1.28% amid a broader rotation out of defensive stocks.